Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease.
AUTOR(ES)
O'Gorman, M R
RESUMO
Chronic granulomatous disease (CGD) is characterized by defective killing of intracellular microorganisms due to mutations in one of the four known components of the NADPH oxidase system. This system is responsible for the generation of superoxide and related antimicrobial oxidants. Diagnosis of CGD requires the demonstration of an abnormal oxidase system in the leukocytes of affected patients. Recently, several flow cytometry-based procedures which measure various reactive oxygen intermediates generated by the NADPH oxidase system have been developed. Most of the procedures developed to date require time-consuming granulocyte isolation, washing, and counting procedures, or they lack sensitivity. We have modified an existing procedure such that cell labelling and stimulation are performed directly in whole blood. Optimization of this procedure and its use in the diagnosis of patients with CGD or X-linked carriers are presented.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=170133Documentos Relacionados
- Rapid whole-blood microassay using flow cytometry for measuring neutrophil phagocytosis.
- Diagnosis of Lyme Borreliosis by a Whole-Blood Gamma Interferon Assay for Cell-Mediated Immune Responses
- A Whole-Blood Assay for Qualitative and Semiquantitative Measurements of CD69 Surface Expression on CD4 and CD8 T Lymphocytes Using Flow Cytometry
- Diagnostic accuracy of a rapid whole-blood test for detection of Helicobacter pylori.
- Whole-Blood Agglutination Assay for On-Site Detection of Human Immunodeficiency Virus Infection
